YIELD10 BIOSCIENCE INC (YTEN) Stock Price & Overview
NASDAQ:YTEN • US98585K8541
Current stock price
The current stock price of YTEN is 2.88 USD. Today YTEN is down by -45.25%. In the past month the price decreased by -56.91%. In the past year, price decreased by -96.01%.
YTEN Key Statistics
- Market Cap
- 44.352M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -32.44
- Dividend Yield
- N/A
YTEN Stock Performance
YTEN Stock Chart
YTEN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to YTEN. When comparing the yearly performance of all stocks, YTEN is a bad performer in the overall market: 99.25% of all stocks are doing better.
YTEN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to YTEN. YTEN may be in some trouble as it scores bad on both profitability and health.
YTEN Earnings
YTEN Forecast & Estimates
7 analysts have analysed YTEN and the average price target is 12.24 USD. This implies a price increase of 325% is expected in the next year compared to the current price of 2.88.
For the next year, analysts expect an EPS growth of 97.63% and a revenue growth 2712.5% for YTEN
YTEN Groups
Sector & Classification
YTEN Financial Highlights
Over the last trailing twelve months YTEN reported a non-GAAP Earnings per Share(EPS) of -32.44. The EPS decreased by -1075.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -370% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
YTEN Ownership
YTEN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 388.432B | ||
| AMGN | AMGEN INC | 16.04 | 197.413B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 179.993B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 119.226B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.843B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 41.564B | ||
| INSM | INSMED INC | N/A | 30.069B | ||
| BIIB | BIOGEN INC | 11.29 | 26.644B | ||
| NTRA | NATERA INC | N/A | 26.624B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.498B | ||
| MRNA | MODERNA INC | N/A | 20.758B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.77B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.798B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About YTEN
Company Profile
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2006-11-10. The firm is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. The company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The firm's development pipeline falls into three categories: input traits, performance traits and new seed product traits.
Company Info
IPO: 2006-11-10
YIELD10 BIOSCIENCE INC
19 Presidential Way Ste 201
Woburn MASSACHUSETTS 01801 US
CEO: Oliver P. Peoples
Employees: 30
Phone: 16175831700
YIELD10 BIOSCIENCE INC / YTEN FAQ
Can you describe the business of YIELD10 BIOSCIENCE INC?
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 30 full-time employees. The company went IPO on 2006-11-10. The firm is using its differentiated trait gene discovery platform, the TraitFactory, to develop improved Camelina varieties for the production of seed products, and to discover high value genetic traits for the agriculture and food industries. The seed products include Camelina oil for use as a low carbon biofuel feedstock, Omega-3 oils for nutrition and PHA Bioplastics for biodegradable zero-waste packaging solutions. The company is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low carbon sustainable seed products to address petroleum replacement markets, food and nutrition markets, and animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits. The firm's development pipeline falls into three categories: input traits, performance traits and new seed product traits.
Can you provide the latest stock price for YIELD10 BIOSCIENCE INC?
The current stock price of YTEN is 2.88 USD. The price decreased by -45.25% in the last trading session.
Does YTEN stock pay dividends?
YTEN does not pay a dividend.
What is the ChartMill technical and fundamental rating of YTEN stock?
YTEN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is YIELD10 BIOSCIENCE INC (YTEN) stock traded?
YTEN stock is listed on the Nasdaq exchange.
What is the expected growth for YTEN stock?
The Revenue of YIELD10 BIOSCIENCE INC (YTEN) is expected to grow by 2712.5% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of YTEN stock?
YIELD10 BIOSCIENCE INC (YTEN) has a market capitalization of 44.35M USD. This makes YTEN a Nano Cap stock.